EUVIMEDEUVIMED entdecken
Open Access

Classification of recurrent implantation failure patients using peripheral blood immunological and metabolic markers

Sina Baharaghdam iD, Özkan Yildirim, Mohammadbagher Pirouzpanah, Danial Abbas Kabiri, Shima Karimi, Mohammad Esfini Farahani, Amirhossein Aghapour, Ali Hassanzadeh, Amin Kamrani, Reza Mousavi Ardehaie, Amir Mehdizadeh, Parvin Hakimi und 3 weitere

BioImpacts · 09.06.2026 · 16 · 33372

DOI: 10.34172/bi.33372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioImpacts, online erschienen am 09.06.2026. Verfasst von Sina Baharaghdam und 14 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recurrent implantation failure (RIF) is a complex condition that makes it one of the most challenging cases in the field of infertility. The diagnosis of this condition with the immunological etiology may be aided by determining the endometrial immune profile for the classification of these patients. Current diagnostic approaches are based on invasive endometrial biopsies to classify patients into balanced, low, or over-immune activation profiles, which have limitations for routine use and serial monitoring. This study aimed to develop and validate a minimally invasive peripheral blood-based classification system using immunological and metabolic markers to mirror endometrial immune profiles in RIF patients.

Methods

Endometrial tissue and peripheral blood samples were collected during the mid-luteal phase from 163 RIF patients and 28 fertile controls. Endometrial immune profiles were determined via RT-qPCR for IL-18, IL-15, TWEAK, Fn-14, and CD56, classifying RIF into balanced, low, and over-immune activation subgroups, with sample sizes of 32, 47, and 84 women, respectively. Peripheral blood was analyzed by flow cytometry to determine the Th1/Th2 ratio and NK cell percentage; by ELISA to measure nuclear antibodies (ANA, anti-dsDNA), phospholipid-related antibodies (anticardiolipin, anti-β2-glycoprotein I, antiphospholipid antibodies), thyroid-related antibodies (anti-TPO, anti-TG), anti-tissue transglutaminase (anti-TTG), and metabolites (S1P, adiponectin, leptin, PGE2, phosphatidylserine, IGF-1); and by spectrophotometry to quantify total phospholipids.

Results

The over-immune activation group showed significantly elevated Th1/Th2 ratios, NK-cell percentages, and autoantibodies (ANA, anti-phospholipid, anti-β2-glycoprotein I, anti-TG, anti-TPO) compared to balanced and low-immune activation groups. Metabolic profiles revealed higher leptin, and total phospholipids but lower adiponectin, S1P, and PGE2 in over-immune activation group. The low-activation group exhibited lower Th1/Th2 ratios, reduced leptin, but elevated adiponectin, S1P, and PGE2 versus balanced and over-immune activation groups. No significant differences were found in phosphatidylserine or IGF-1 across groups.

Conclusion

Our results demonstrate that peripheral blood immunological and metabolic markers can effectively distinguish RIF immune endotypes, offering a non-invasive alternative to endometrial biopsy for personalized assisted reproductive technology (ART) management and potentially improving implantation success through targeted therapies.

Schlagwörter

Stichwörter der Autor:innen

Immune profileInfertilityPersonalized treatmentRecurrent implantation failure

Autor:innen und Institutionen

  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Histology and Embryology, Institute of Health Sciences, Atatürk University, Erzurum, Türkiye.
  • Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, USA.
  • Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Sina Baharaghdam, Mehdi Yousefi

Zitieren

APA

Baharaghdam, S., Yildirim, Ö., Pirouzpanah, M., Abbas Kabiri, D., Karimi, S., Esfini Farahani, M., Aghapour, A., Hassanzadeh, A., Kamrani, A., Mousavi Ardehaie, R., Mehdizadeh, A., Hakimi, P., Ahmadian Heris, J., Aghebati-Maleki, L., & Yousefi, M. (2026). Classification of recurrent implantation failure patients using peripheral blood immunological and metabolic markers. BioImpacts, 16, 33372. https://doi.org/10.34172/bi.33372

Vancouver

Baharaghdam S, Yildirim Ö, Pirouzpanah M, Abbas Kabiri D, Karimi S, Esfini Farahani M, et al. Classification of recurrent implantation failure patients using peripheral blood immunological and metabolic markers. BioImpacts. 2026;16:33372. doi:10.34172/bi.33372

BibTeX
@article{Baharaghdam2026,
  author = {Baharaghdam, Sina and Yildirim, Özkan and Pirouzpanah, Mohammadbagher and Abbas Kabiri, Danial and Karimi, Shima and Esfini Farahani, Mohammad and Aghapour, Amirhossein and Hassanzadeh, Ali and Kamrani, Amin and Mousavi Ardehaie, Reza and Mehdizadeh, Amir and Hakimi, Parvin and Ahmadian Heris, Javad and Aghebati-Maleki, Leili and Yousefi, Mehdi},
  title = {Classification of recurrent implantation failure patients using peripheral blood immunological and metabolic markers},
  journal = {BioImpacts},
  year = {2026},
  volume = {16},
  pages = {33372},
  doi = {10.34172/bi.33372}
}
Kostenlos starten →